Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-04-19 @ 9:27 AM
Study NCT ID:
NCT00234494
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2005-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
Sponsor:
Christopher Sweeney, MBBS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOG GU04-75
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None